Caxton Corporation’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-1,999
| Closed | -$233K | – | 28 |
|
|
2018
Q1 | $233K | Sell |
1,999
-419
| -17% | -$48.8K | 0.25% | 18 |
|
|
2017
Q4 | $222K | Buy |
+2,418
| New | +$222K | 0.27% | 16 |
|
|
2016
Q4 | – | Sell |
-506,738
| Closed | -$6.43M | – | 15 |
|
|
2016
Q3 | $6.43M | Sell |
506,738
-115,281
| -19% | -$1.46M | 28.77% | 2 |
|
|
2016
Q2 | $5.67M | Buy |
622,019
+1,881
| +0.3% | +$17.1K | 6.39% | 3 |
|
|
2016
Q1 | $5.21M | Buy |
620,138
+227
| +0% | +$1.91K | 7.19% | 3 |
|
|
2015
Q4 | $7.64M | Sell |
619,911
-439,207
| -41% | -$5.41M | 32.03% | 1 |
|
|
2015
Q3 | $64.5M | Buy |
1,059,118
+227
| +0% | +$13.8K | 87% | 1 |
|
|
2015
Q2 | $82.6M | Buy |
1,058,891
+87
| +0% | +$6.79K | 87.47% | 1 |
|
|
2015
Q1 | $71.9M | Buy |
1,058,804
+196,006
| +23% | +$13.3M | 85.78% | 1 |
|
|
2014
Q4 | $80M | Buy |
862,798
+87
| +0% | +$8.07K | 92.06% | 1 |
|
|
2014
Q3 | $90.9M | Buy |
862,711
+8,658
| +1% | +$912K | 93.55% | 1 |
|
|
2014
Q2 | $122M | Buy |
854,053
+35,786
| +4% | +$5.12M | 94.25% | 1 |
|
|
2014
Q1 | $123M | Sell |
818,267
-72
| -0% | -$10.9K | 94.21% | 1 |
|
|
2013
Q4 | $150M | Buy |
818,339
+143,072
| +21% | +$26.2M | 95.29% | 1 |
|
|
2013
Q3 | $149M | Buy |
675,267
+71
| +0% | +$15.7K | 99.87% | 1 |
|
|
2013
Q2 | $118M | Buy |
+675,196
| New | +$118M | 99.78% | 1 |
|